0001698530-17-000004.txt : 20171010 0001698530-17-000004.hdr.sgml : 20171009 20171010131420 ACCESSION NUMBER: 0001698530-17-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171010 DATE AS OF CHANGE: 20171010 EFFECTIVENESS DATE: 20171010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXICURE, INC. CENTRAL INDEX KEY: 0001698530 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 815333008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296273 FILM NUMBER: 171129816 BUSINESS ADDRESS: STREET 1: 8045 LAMON AVE, SUITE 410 CITY: SKOKIE STATE: IL ZIP: 60077 BUSINESS PHONE: 847-673-1700 MAIL ADDRESS: STREET 1: 8045 LAMON AVE, SUITE 410 CITY: SKOKIE STATE: IL ZIP: 60077 FORMER COMPANY: FORMER CONFORMED NAME: Max-1 Acquisition Corp DATE OF NAME CHANGE: 20170221 D 1 primary_doc.xml X0708 D LIVE 0001698530 EXICURE, INC. 8045 LAMON AVE, SUITE 410 SKOKIE IL ILLINOIS 60077 847-673-1700 DELAWARE Max-1 Acquisition Corp Corporation true 2017 Chad Mirkin 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Director C. Shad Thaxton 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Director David A. Giljohann 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Executive Officer Director David R. Walt 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Director David S. Snyder 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Executive Officer Helen S. Kim 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Director Jay R. Venkatesan 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Director Ekambar Kandimalla 8045 Lamon Avenue Suite 410 Skokie IL ILLINOIS 60077 Executive Officer Biotechnology Decline to Disclose 06b false 2017-09-26 false true true Issuer's subsidiary merged with & into Exicure, Inc. ("OpCo") with OpCo surviving & becoming Issuer's wholly-owned subsidiary. OpCo's outstanding capital stock converted into Issuer's common stock. OpCo changed its name & Issuer adopted "Exicure, Inc." 0 43090544 43090544 0 Issuer's subsidiary merged with & into Exicure, Inc. ("OpCo") with OpCo surviving & becoming Issuer's wholly-owned subsidiary. OpCo's outstanding capital stock converted into Issuer's common stock. OpCo changed its name & Issuer adopted "Exicure, Inc." true 3 84 0 0 0 false EXICURE, INC. /s/David A. Giljohann David A. Giljohann Chief Executive Officer 2017-10-10